We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.1B
1-Year Est. Return 4.68%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+4.68%
3 Year Est. Return
+8.24%
5 Year Est. Return
+32.95%
10 Year Est. Return
–
AUM
$2.25B
AUM Growth
+$659M
Cap. Flow
+$254M
Cap. Flow %
11.31%
Top 10 Hldgs %
77.66%
Holding
99
New
21
Increased
28
Reduced
5
Closed
29

Top Buys

Rank Stock Value
1
TIF
Tiffany & Co.
TIF
+$75.4M
2
EE
El Paso Electric Company
EE
+$56.1M
3
ADSW
Advanced Disposal Services Inc
ADSW
+$47M
4
WTW icon
Willis Towers Watson
WTW
+$34.4M
5
WMGI
Wright Medical Group Inc
WMGI
+$30.8M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$66.9M
2
AXE
Anixter International Inc
AXE
+$33.1M
3
WBC
WABCO HOLDINGS INC.
WBC
+$32.4M
4
S
Sprint Corporation
S
+$25.9M
5
FTSV
Forty Seven, Inc. Common Stock
FTSV
+$23.9M

Sector Composition

Rank Sector Weight
1 Utilities 5%
2 Financials 4.61%
3 Healthcare 4.37%
4 Industrials 4%
5 Technology 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VAC icon
51
Marriott Vacations Worldwide
VAC
$3.35B
$668K 0.03%
+8,127
New +$662K
BKNG icon
52
PUT
Booking.com
BKNG
$145B
$319K 0.01%
+5,000
New +$304K
BURL icon
53
PUT
Burlington
BURL
$22.4B
$296K 0.01%
+1,500
New +$283K
ACOR
54
PUT
DELISTED
Acorda Therapeutics
ACOR
$156K 0.01%
1,770
+33
+2% +$3.49K
APLS
55
PUT
DELISTED
Apellis Pharmaceuticals
APLS
– –
-29,300
Closed -$778K
AVDL
56
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-322,400
Closed -$2.56M
BMRN icon
57
CALL
BioMarin Pharmaceuticals
BMRN
$11.8B
– –
-31,900
Closed -$2.69M
BMRN icon
58
BioMarin Pharmaceuticals
BMRN
$11.8B
– –
-23,720
Closed -$2M
BMRN icon
59
PUT
BioMarin Pharmaceuticals
BMRN
$11.8B
– –
-30,600
Closed -$2.58M
COOP
60
CALL
DELISTED
Mr. Cooper
COOP
– –
-144,000
Closed -$1.05M
COOP
61
DELISTED
Mr. Cooper
COOP
– –
-25,000
Closed -$183K
HXL icon
62
Hexcel
HXL
$8.25B
– –
-263,662
Closed -$9.81M
PPLI
63
PUT
People Inc
PPLI
$3.14B
– –
-61,549
Closed -$1.97M
RTX icon
64
RTX Corp
RTX
$297B
– –
-333,690
Closed -$19.8M
CBAY
65
CALL
DELISTED
Cymabay Therapeutics
CBAY
– –
-201,100
Closed -$294K
NAV
66
DELISTED
Navistar International
NAV
– –
-80,000
Closed -$1.32M
FIT
67
DELISTED
Fitbit, Inc. Class A common stock
FIT
– –
-100,000
Closed -$666K
FIT
68
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
– –
-500,000
Closed -$3.33M
TIF
69
CALL
DELISTED
Tiffany & Co.
TIF
– –
-302,800
Closed -$39.2M
WMGI
70
PUT
DELISTED
Wright Medical Group Inc
WMGI
– –
-96,200
Closed -$2.76M
AMTD
71
DELISTED
TD Ameritrade Holding Corp
AMTD
– –
-70,000
Closed -$2.43M
LOGM
72
DELISTED
LogMein, Inc.
LOGM
– –
-51,872
Closed -$4.32M
TECD
73
CALL
DELISTED
Tech Data Corp
TECD
– –
-3,200
Closed -$418K
AXE
74
DELISTED
Anixter International Inc
AXE
– –
-376,900
Closed -$33.1M
FG
75
DELISTED
FGL Holdings Ordinary Shares
FG
– –
-2,394,584
Closed -$23.5M
1 2
3
4

Similar funds

PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
AC
AWM Capital Phoenix, Arizona $1.1B AUM 15.03% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

DLD Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, DLD Asset Management held 99 positions worth $2.25B, up 41% from $1.59B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

DLD Asset Management deployed $254M of net new capital in Q2 2020, opening 21 new positions and adding to 28 existing holdings. Its largest new stake was Portola Pharmaceuticals, Inc.: 1,172,623 shares worth $21.1M.

By sector, the portfolio is most concentrated in Utilities at 5% of assets, up from 3.6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Taubman Centers Inc., an estimated $4.09M trimmed.

  • DLD Asset Management's largest Q2 2020 buy was Portola Pharmaceuticals, Inc.: 1,172,623 shares worth $21.1M.
  • DLD Asset Management added most to Tiffany & Co. in Q2 2020, an estimated $75.4M increase.
  • DLD Asset Management's biggest Q2 2020 reduction was Taubman Centers Inc., cutting an estimated $4.09M.
  • DLD Asset Management fully exited Allergan plc in Q2 2020, selling an estimated $66.9M.
  • DLD Asset Management's ten largest holdings make up 78% of its $2.25B portfolio in Q2 2020.
  • DLD Asset Management opened 21 new positions and closed 29 in Q2 2020.
  • DLD Asset Management's portfolio value rose 41% quarter-over-quarter to $2.25B.

Based on DLD Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.